This compound is a protected pseudouridine derivative used as a pharmaceutical intermediate in nucleoside synthesis. It features a dimethoxytrityl (DMT) protecting group at the 5' position and a tert-butyldimethylsilyl (TBDMS) group at the 2' position, enabling selective chemical modifications during RNA-related research and manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 144429-56-1
5'-DMT-3'-O-TBDMS-PseudoUridine
pharmaceutical intermediate for modified nucleosides
5'-DMT-PseudoUridine
Pharmaceutical intermediate for oligonucleotide synthesis
5'-O-(4,4'-Dimethoxitrityl)-2'-O-(tert-butyldimethylsilyl)-1-N-methylpseudouridine
Pharmaceutical intermediate for modified nucleosides
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
((3aR,4R,6R,6aR)-2,2-Dimethyl-6-(2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydro-2H-furo(3,4-d)(1,3)dioxol-4-yl)methyl 2-methylpropanoate
Pharmaceutical intermediate for nucleoside synthesis
Cytidine, N-benzoyl-2'-deoxy-5-methyl-
Pharmaceutical intermediate for nucleoside synthesis
N-benzoylcytidine
Pharmaceutical intermediate for nucleoside synthesis
1,2,3,4-tetrahydroisoquinolin-6-ol
pharmaceutical intermediate
5-[(2S,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxyoxolan-2-yl]-1H-pyrimidine-2,4-dione
ZWMZNCKRGUDPLZ-FEFKUCBWSA-N
CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H]([C@H](O[C@H]1C2=CNC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O
—